Investor Type | Firm |
Type of Fund | VC |
Industries | BioTech • AgroTech • Hardware (& Manufacturing) • Food & Beverage • Impact • Material Science • DeepTech • Pharmaceutical (& Medicine) • Woman Focused |
Stages | Pre-Seed, Seed, Early Stage |
Investing | United States |
Investment Range | $100,000 - $1,000,000 |
Investment Sweet Spot | $250,000 |
MarsBio is a venture capital firm based in the USA that specializes in Pre-Seed, Seed, and Early Stage investments, with a focus on Biotech, AgroTech, Hardware & Manufacturing, Food & Beverage, Impact, Material Science, DeepTech, and Pharmaceutical & Medicine sectors. The firm is particularly interested in biotech and synthetic biology, aiming to make revolutionary advancements in health, food, agriculture, consumer, materials, and energy. MarsBio's investments range from a minimum of $100,000 to a maximum of $1,000,000, with a sweet spot of approximately $250,000 for investments. MarsBio prides itself on backing the boldest bioscience entrepreneurs at the earliest stages of their venture. Through a message on their website, the firm reveals its vision for a society where advancements in bioscience lead to significant improvements in longevity, health, and the availability of cures, reflecting a profound sense of anticipation for future innovation similar to the awe experienced by our ancestors witnessing the first cars, airplanes, or plastic. MarsBio aspires to contribute to the kind of scientific progress that not only extends the boundaries of knowledge through methodical experimentation and categorization but also seeks the revolutionary leaps of genius that redefine what is possible. Their dedication is to not only remember the former type of progress but to fervently pursue the latter as well.